title: Novel oral anticoagulants in gastroenterology practice.
authors.affiliation: Department of Medicine Division of Gastroenterology, New York University, New York, New York, USA.
authors.forename: Jay
authors.initials: J
authors.lastname: Desai
authors.forename: Christopher B
authors.initials: CB
authors.lastname: Granger
authors.forename: Jeffrey I
authors.initials: JI
authors.lastname: Weitz
authors.forename: James
authors.initials: J
authors.lastname: Aisenberg
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects* / Q000494:pharmacology; D000991:Antithrombins / Q000009:adverse effects / Q000494:pharmacology; D001281:Atrial Fibrillation / Q000150:complications; D001562:Benzimidazoles / Q000009:adverse effects / Q000494:pharmacology; D000069604:Dabigatran; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D009025:Morpholines / Q000009:adverse effects / Q000494:pharmacology; D011720:Pyrazoles / Q000009:adverse effects / Q000494:pharmacology; D011725:Pyridines / Q000009:adverse effects / Q000494:pharmacology; D011728:Pyridones / Q000009:adverse effects / Q000494:pharmacology; D000069552:Rivaroxaban; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013876:Thiophenes / Q000009:adverse effects / Q000494:pharmacology
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D001562:Benzimidazoles; D009025:Morpholines; D011720:Pyrazoles; D011725:Pyridines; D011728:Pyridones; D013876:Thiophenes; C522181:apixaban; D000069552:Rivaroxaban; D000069604:Dabigatran
keywords: AF; ARISTOTLE; ASGE; American Society for Gastrointestinal Endoscopy; INR; NOAC; NSAID; PCC; PPI; PT; RE-LY; ROCKET-AF; RR; aPTT; activated partial thromboplastin time; apixaban for reduction in stroke and thromboembolic events in atrial fibrillation; atrial fibrillation; international normalized ratio; nonsteroidal anti-inflammatory drug; novel oral anticoagulant; prothrombin complex concentrate; prothrombin time; proton pump inhibitor; randomized evaluation of long term anticoagulant therapy; relative risk; rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation